Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PCRESOL
Stock Latest News
Private Companies
Resolution Therapeutics Builds Clinical and Operational Momentum Ahead of Key RTX001 Trial Readouts
5h ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights Progress of EMERALD Trial for End-Stage Liver Disease
1d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Nears Interim Data for RTX001 in Phase I/II EMERALD Trial
1d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights Ongoing EMERALD Trial for Regenerative Liver Therapy
3d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Executive Highlights Evolving Clinical Trial Practices
3d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights Progress of EMERALD Trial for End-Stage Liver Disease
3d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights Evolving Clinical Trial Practices in Industry Q&A
3d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Builds Momentum Around RTX001 as Preclinical Data and Conference Visibility Grow
7d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights Preclinical Liver Therapy Data Ahead of 2026 Trial Milestone
11d ago
RESOL
Premium
Private Companies
Preclinical Liver Therapy Data Highlighted Ahead of RTX001 Phase I/II Readout
11d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Showcases Preclinical Strength of RTX001 Ahead of EMERALD Readout
11d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights RTX001 in Context of Shifting Cell and Gene Therapy Landscape
12d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights Regenerative Cell Therapy Focus and RTX001 Positioning
12d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Builds Scientific and Clinical Momentum Around RTX001
14d ago
RESOL
Premium
Private Companies
Resolution Therapeutics to Present RTX001 Data at Major Gene and Cell Therapy Meeting
15d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Showcases RTX001 Liver Disease Program at ASGCT 2026
15d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights Macrophage Therapy Platform and RTX001 Clinical Progress
16d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights Macrophage-Based Cell Therapy Program at ISCT 2026
16d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights Proactive Regulatory Focus in Cell Therapy Development
18d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Builds Momentum Around RTX001 and EMERALD Trial
21d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights Clinical Progress in Regenerative Macrophage Therapy
22d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights Clinical Presence and ESLD Program at Major Hepatology Meeting
22d ago
RESOL
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
